Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$70.78
-5.74-7.5%
Last update: Oct 16, 4:44 PM
$70.78
-5.74-7.5%
TransMedics Group Inc (TMDX) Stock Price, Quote, News & History
TMDXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of TransMedics Group (NASDAQ:TMDX) through any online brokerage.
Other companies in TransMedics Group’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
TransMedics Group has a consensus price target of $112.79.
The stock price for TransMedics Group (NASDAQ: TMDX) is $70.78 last updated October 16, 2026 at 4:44 PM EDT.
There are no upcoming dividends for TransMedics Group.
TransMedics Group does not have any upcoming earnings scheduled.
There is no upcoming split for TransMedics Group.
TransMedics Group is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
